Saccharopine Dehydrogenases [sacharopindehydrogenasy]

topical
Terms

LKR
lysin-ketoglutarát reduktáza
NAD+-dependentní sacharopindehydrogenasa (produkující L-glutamát)
NAD+-dependentní sacharopindehydrogenasa (produkující L-lysin)
NAD+-dependentní sacharopindehydrogenáza (produkující L-glutamát)
NAD+-dependentní sacharopindehydrogenáza (produkující L-lysin)
NADP+-dependentní sacharopindehydrogenasa (produkující L-glutamát)
NADP+-dependentní sacharopindehydrogenasa (produkující L-lysin)
NADP+-dependentní sacharopindehydrogenáza (produkující L-glutamát)
NADP+-dependentní sacharopindehydrogenáza (produkující L-lysin)
sacharopin dehydrogenasy (terminologicky nesprávně)
sacharopin dehydrogenázy (terminologicky nesprávně)
sacharopindehydrogenázy

 

Lysine-2-Oxoglutarate Reductase
Lysine-Ketoglutarate Reductase
Saccharopine Dehydrogenase
Saccharopine Dehydrogenase (NAD+, L-Glutamate Forming)
Saccharopine Dehydrogenase (NAD+, L-Lysine Forming)
Saccharopine Dehydrogenase (NADP+, L-Glutamate Forming)
Saccharopine Dehydrogenase (NADP+, L-Lysine Forming)

Persistent link   https://www.medvik.cz/link/D012443
Definition

Amine oxidoreductases that use either NAD+ (EC 1.5.1.7) or NADP+ (EC 1.5.1.8) as an acceptor to form L-LYSINE or NAD+ (EC 1.5.1.9) or NADP+ (EC 1.5.1.10) as an acceptor to form L-GLUTAMATE. Deficiency of this enzyme causes HYPERLYSINEMIAS.

Annotation
/defic: consider also HYPERLYSINEMIAS
DUI
D012443 MeSH Browser
CUI
M0019332
Previous indexing
Ketoglutaric Acids (1972-1974); Lysine (1970-1974); Oxidoreductases (1970-1974)
History note
91(75); was see under AMINE OXIDOREDUCTASES 1975-90
Public note
91; was see under AMINE OXIDOREDUCTASES 1975-90

Allowable subheadings

AD
administration & dosage
AE
adverse effects
AN
analysis
AI
antagonists & inhibitors
BI
biosynthesis
BL
blood
CF
cerebrospinal fluid
CS
chemical synthesis
CH
chemistry
CL
classification
DF
deficiency
DE
drug effects
EC
economics
GE
genetics
HI
history
IM
immunology
IP
isolation & purification
ME
metabolism
PK
pharmacokinetics
PD
pharmacology
PH
physiology
PO
poisoning
RE
radiation effects
ST
standards
SD
supply & distribution
TU
therapeutic use
TO
toxicity
UL
ultrastructure
UR
urine

D Chemicals and Drugs
D01 Inorganic Chemicals 68
D02 Organic Chemicals 391
D03 Heterocyclic Compounds 190
D04 Polycyclic Compounds 65
D05 Macromolecular Substances 103
D06 Hormones, Hormone Substitutes, and Hormone Antagonists 43
D08 Enzymes and Coenzymes 7
D08.811 Enzymes 1 551
D08.811.682 Oxidoreductases 446
D08.811.682.662 Oxidoreductases Acting on CH-NH Group Donors 7
D08.811.682.662.171 FMN Reductase 10
D08.811.682.662.217 Methylenetetrahydrofolate Dehydrogenase (NAD+)
D08.811.682.662.253 Methylenetetrahydrofolate Dehydrogenase (NADP) 5
D08.811.682.662.290 Methylenetetrahydrofolate Reductase (NADPH2) 69
D08.811.682.662.436 mu-Crystallins
D08.811.682.662.582 Oxidoreductases, N-Demethylating 10
D08.811.682.662.611 Polyamine Oxidase
D08.811.682.662.640 Proline Oxidase 2
D08.811.682.662.680 Pyridoxaminephosphate Oxidase
D08.811.682.662.693 1-Pyrroline-5-Carboxylate Dehydrogenase 1
D08.811.682.662.695 Pyrroline Carboxylate Reductases
D08.811.682.662.750 Saccharopine Dehydrogenases
D08.811.682.662.825 Tetrahydrofolate Dehydrogenase 16
D09 Carbohydrates 724
D10 Lipids 2 528
D12 Amino Acids, Peptides, and Proteins 16
D13 Nucleic Acids, Nucleotides, and Nucleosides 9
D20 Complex Mixtures 19
D23 Biological Factors 143
D25 Biomedical and Dental Materials 110
D26 Pharmaceutical Preparations 7 045
D27 Chemical Actions and Uses 374

AASS protein, human Chemical MeSH Browser

Aass protein, mouse Chemical MeSH Browser

saccharopine dehydrogenase (NADP+, lysine-forming) Chemical MeSH Browser

saccharopine dehydrogenase (NADP, L-glutamate-forming) Chemical MeSH Browser

Back Add